Prescribing trends in treatment-resistant schizophrenia


GÖRMEZ A., KURTULMUŞ A. , Tuncer C., Çıtak S.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, vol.27, no.4, pp.419-426, 2017 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.1080/24750573.2017.1370767
  • Title of Journal : PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
  • Page Numbers: pp.419-426

Abstract

Objectives: Schizophrenia is a common mental health condition associated with significant morbidity and excess early mortality. Treatment-resistant schizophrenia (TRS) occurs in about one in three patients diagnosed with schizophrenia. The aim of this study was to identify attitudes of a nationally representative sample of psychiatrists towards pharmacotherapy of patients with TRS, the potential factors related to their choice of various regimens, and to investigate the clinical outcomes of different methods employed.